Inventor · disambiguated record
Karen Manucharyan
Also filed as: MANUCHARYAN KAREN
6 granted patents·5 pending applications·8 citations·filing 2004–2023
74Inventor score
Files withPRIMEX CLINICAL LABORATORIES INC3MANUCHARYAN KAREN2PRIMEX CLINICAL LAB INC2PRIMEX CLINICAL LABORATORIES2SCIUTTO CONDE EDDA LYDIA1
Top patents by PatentIndex Score
11 records- 0175US8394380B2Compositions and methods for alzheimer's diseaseMANUCHARYAN KAREN·Filed 2010·Granted Mar 12, 2013·3 cites·12 claims
- 0275US7846892B2Compositions and methods for Alzheimer's diseasePRIMEX CLINICAL LAB INC·Filed 2007·Granted Dec 7, 2010·4 cites·12 claims
- 0370US2024076802A1Variable epitope library compositions and methods of therapeutic and prophylactic usePRIMEX CLINICAL LABORATORIES INC·Filed 2023·Application pending·0 cites
- 0469US10383927B2Variable epitope library compositions and methods of therapeutic and prophylactic usePRIMEX CLINICAL LABORATORIES INC·Filed 2016·Granted Aug 20, 2019·1 cites·21 claims
- 0565US11781247B2Variable epitope library compositions and methods of therapeutic and prophylactic usePRIMEX CLINICAL LABORATORIES INC·Filed 2019·Granted Oct 10, 2023·0 cites·13 claims
- 0654US2006024667A1Compositions and methods for Alzheimer's diseaseMANUCHARYAN KAREN·Filed 2004·Application pending·0 cites
- 0749US2021338806A1METHODS OF GENERATING VACCINES AGAINST NOVEL CORONAVIRUS, NAMED SARS-COV-2 COMPRISING VARIABLE EPITOPE LIBRARIES (VELs) AS IMMUNOGENSPRIMEX CLINICAL LABORATORIES·Filed 2021·Application pending·0 cites
- 0842US2019339287A1Identification and generation of personalized vaccine components by functional screening variable epitope and mimotope librariesPRIMEX CLINICAL LABORATORIES·Filed 2019·Application pending·0 cites
- 0936US11020449B2Use of the GK-1 peptide as an antitumoral and/or antimetastatic agentUNIV MEXICO NAC AUTONOMA·Filed 2017·Granted Jun 1, 2021·0 cites·9 claims
- 1036US2009214591A1Immunogens for Vaccines Against Antigenically Variable Pathogens and DiseasesPRIMEX CLINICAL LAB INC·Filed 2006·Application pending·0 cites
- 1127US9446122B2Use of GK-1 peptide expressed on M13 filamentous phage as pharmaceutical ingredient to enhance the efficiency of the immune response induced by vaccine or pathogen antigensSCIUTTO CONDE EDDA LYDIA·Filed 2012·Granted Sep 20, 2016·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Karen Manucharyan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →